(S (NP (NP (DT The) (JJ current) (NN state)) (PP (IN of) (NP (NN cancer) (NNS therapeutics)))) (VP (VBZ has) (VP (VBN been) (VP (VBG moving) (ADVP (RB away)) (PP (PP (IN from) (S (NP (CD one) (HYPH -) (NN size)) (HYPH -) (VP (VBZ fits) (HYPH -) (NP (DT all) (JJ cytotoxic) (NN chemotherapy))))) (, ,) (CC and) (PP (IN towards) (NP (NP (DT a) (ADJP (RBR more) (JJ individualized) (CC and) (JJ specific)) (NN approach)) (PP (VBG involving) (NP (NP (DT the) (NN targeting)) (PP (IN of) (NP (NP (DT each) (NN tumor) (POS 's)) (JJ genetic) (NNS vulnerabilities))))))))))) (. .))
(S (NP (NP (JJ Different) (NNS tumors)) (, ,) (PP (ADVP (RB even)) (IN of) (NP (DT the) (JJ same) (NN type))) (, ,)) (VP (MD may) (VP (VB be) (ADJP (ADJP (RBR more) (JJ reliant)) (PP (IN on) (NP (JJ certain) (JJ cellular) (NNS pathways)))) (ADVP (RBR more) (PP (IN than) (NP (NNS others)))))) (. .))
(S (PP (IN With) (NP (NP (JJ modern) (NNS advancements)) (PP (IN in) (NP (NP (PRP$ our) (NN understanding)) (PP (IN of) (NP (NML (NN cancer) (NN genome)) (NN sequencing))))))) (, ,) (NP (DT these) (NNS pathways)) (VP (MD can) (VP (VB be) (VP (VBN discovered)))) (. .))
(S (S (VP (VBG Investigating) (NP (NP (DT each)) (PP (IN of) (NP (NP (DT the) (NNS millions)) (PP (IN of) (NP (JJ possible) (JJ small) (NN molecule) (NNS inhibitors)))))) (PP (IN for) (NP (NP (DT each) (NN kinase)) (ADJP (FW in) (FW vitro)))))) (, ,) (ADVP (RB however)) (, ,) (VP (MD would) (VP (VB be) (ADJP (ADJP (RB extremely) (JJ expensive)) (CC and) (ADJP (NN time) (VBG consuming))))) (. .))
(S (NP (DT This) (NN project)) (VP (VBZ focuses) (PP (IN on) (S (VP (VBG predicting) (NP (NP (DT the) (NN inhibition) (NN activity)) (PP (IN of) (NP (NP (JJ small) (NNS molecules)) (VP (VBG targeting) (NP (CD 8) (JJ different) (NNS kinases)) (S (VP (VBG using) (NP (JJ multiple) (NML (JJ deep) (NN learning)) (NNS models)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD trained) (NP (NP (ADJP (NN fingerprint) (HYPH -) (VBN based)) (NNS MLPs)) (CC and) (NP (NP (VBN simplified) (NML (JJ molecular) (HYPH -) (NN input)) (NML (NN line) (HYPH -) (NN entry)) (NN specification) (PRN (-LRB- -LRB-) (S (VP (VBZ SMILES))) (-RRB- -RRB-))) (HYPH -) (VP (VBN based) (NP (NP (ADJP (JJ recurrent) (NP (NP (NP (JJ neural) (NNS networks)) (-LRB- -LRB-) (NP (NNS RNNs)) (-RRB- -RRB-)) (CC and) (NP (JJ molecular) (NN graph)))) (JJ convolutional) (NNS networks)) (-LRB- -LRB-) (NP (NNS GCNs)) (-RRB- -RRB-)) (S (VP (TO to) (ADVP (RB accurately)) (VP (VB predict) (NP (JJ inhibitory) (NN activity)) (S (VP (VBG targeting) (NP (DT these) (CD 8) (NNS kinases))))))))))) (. .))
